CTNM Contineum Therapeutics, Inc. Class A Common Stock
Healthcare$13.70-1.15%ClosedMarket Cap: $512.2M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
3
Buy/Sell Ratio
0.00
Net Shares
-8,340
Shares Acquired
0
Shares Disposed
8,340
Total Bought ($)
$0.00
Total Sold ($)
$3.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri May 01 | Lorrain Daniel S. | officer: Chief Scientific Officer | Sell | 3,870 | $13.06 | 143,842 |
| Fri May 01 | Lorrain Daniel S. | officer: Chief Scientific Officer | Sell | 300 | $13.84 | 143,542 |
| Mon Apr 06 | Lorrain Daniel S. | officer: Chief Scientific Officer | Sell | 4,170 | $13.43 | 147,712 |
| Mon Mar 02 | Watkins Tim | officer: CMO & Head of Development | Sell | 3,611 | $15.02 | 0 |
| Mon Mar 02 | Watkins Tim | officer: CMO & Head of Development | Sell | 3,611 | $4.50 | 249,167 |
| Mon Mar 02 | Lorrain Daniel S. | officer: Chief Scientific Officer | Sell | 4,170 | $15.01 | 151,882 |
| Thu Feb 26 | Stengone Carmine N. | director, officer: CEO and President | Sell | 4,400 | $16.02 | 14,954 |
| Thu Feb 26 | Stengone Carmine N. | director, officer: CEO and President | Sell | 2,700 | $16.02 | 14,954 |
| Thu Feb 26 | Stengone Carmine N. | director, officer: CEO and President | Sell | 4,400 | $1.26 | 123,617 |
| Thu Feb 26 | Stengone Carmine N. | director, officer: CEO and President | Sell | 2,700 | $1.26 | 120,917 |